Primary Antibodies
Subcategories of "Primary Antibodies"
- Cancer Research Antibodies(3,620 products)
- Cardiovascular Antibodies(2 products)
- Developmental Biology(751 products)
- Epigenetics Antibodies(162 products)
- Immunology Antibodies(2,551 products)
- Metabolism Antibodies(279 products)
- Microbiology Antibodies(739 products)
- Signal Transduction(2,717 products)
- Tags & Cellular Markers(33 products)
Found 75447 products of "Primary Antibodies"
CD49d antibody (Azide Free)
CD49d antibody (Azide free) was raised in rat using the alpha-4 chain of the VLA-4 integrin heterodimer as the immunogen.CD45.1 antibody (PE)
CD45.1 antibody (PE) was raised in mouse using CD45.1 as the immunogen.Purity:Min. 95%Molecular weight:0 g/molCD117 antibody (Spectral Red)
CD117 antibody (Allophycocyanin) was raised in rat using murine CD117/c-Kit as the immunogen.
Purity:Min. 95%Molecular weight:0 g/molCD25 antibody (Allophycocyanin)
CD25 antibody (Allophycocyanin) was raised in rat using IL-2-dependent BALB/c mouse helper T-cell clone HT-2 as the immunogen.Purity:Min. 95%Molecular weight:0 g/molCD11b antibody (Spectral Red)
CD11b antibody (CY5) was raised in rat using C57BL/10 murine splenic T-cells and concanavalin A-activted C57BL/10 splenocytes as the immunogen.Purity:Min. 95%Molecular weight:0 g/molCD3e antibody (FITC)
CD3e antibody (FITC) was raised in mouse using porcine CD3e as the immunogen.
Purity:Min. 95%Molecular weight:0 g/molCD11b antibody (PE)
CD11b antibody (FITC) was raised in rat using peritoneal macrophages from C57 B1/6 x DBA/2 F1 hybrid mice as the immunogen.Purity:Min. 95%Molecular weight:0 g/molCD20 antibody (Allophycocyanin-CY7)
CD20 antibody (Allophycocyanin) was raised in mouse using human CD20 as the immunogen.Purity:Min. 95%Molecular weight:0 g/molCD11a antibody (PE-CY7)
CD11a antibody (PE) was raised in rat using murine CD11a (LFA-1a) as the immunogen.Purity:Min. 95%Molecular weight:0 g/molCD49d antibody (PE)
CD49d antibody (PE) was raised in mouse using human CD49d as the immunogen.Purity:Min. 95%Molecular weight:0 g/molCD45.1 antibody (PE)
CD45.1 antibody (PE-CY7) was raised in mouse using CD45.1 as the immunogen.
Purity:Min. 95%Molecular weight:0 g/molVinculin antibody
The 6-Fluoro-3-indoxyl-beta-D-galactopyranoside is a powerful antituberculosis drug that falls under the class of rifamycins. It is specifically designed to combat tuberculosis infection by targeting active compounds and exhibiting bactericidal activity. This drug inhibits bacterial growth by binding to DNA-dependent RNA polymerase, effectively preventing transcription and replication. Its effectiveness has been demonstrated through extensive research using the patch-clamp technique on human erythrocytes.VEGF antibody
The VEGF antibody is a highly effective inhibitor of vascular endothelial growth factor (VEGF), a key growth factor involved in angiogenesis and the formation of new blood vessels. This antibody specifically targets the VEGF receptor, blocking its activation and preventing the growth and proliferation of endothelial cells.CD19 antibody (FITC)
CD19 antibody (FITC) was raised in mouse using human CD19 as the immunogen.Purity:Min. 95%Molecular weight:0 g/molCD22 antibody (Spectral Red)
CD22 antibody (Spectral Red) was raised in rat using CD22 as the immunogen.
Purity:Min. 95%Molecular weight:0 g/molOxycodone antibody
The Oxycodone antibody is a specific monoclonal antibody that has cytotoxic properties. It is designed to specifically target and neutralize oxycodone, a potent opioid pain medication. This antibody works by binding to the oxycodone molecules and preventing them from interacting with their target receptors in the body. This not only reduces the analgesic effects of oxycodone but also helps to minimize its potential for abuse and addiction. The Oxycodone antibody has been extensively tested in various preclinical models and has shown promising results in reducing the effects of oxycodone overdose. It has the potential to be used as an effective therapeutic option for managing opioid addiction and overdose cases.Purity:Min. 95%CD23 antibody (Allophycocyanin)
CD23 antibody (Allophycocyanin) was raised in rat using CD23 low affinity IgE Fc receptor as the immunogen.Purity:Min. 95%Molecular weight:0 g/molCD3e antibody (FITC)
CD3e antibody (FITC) was raised in mouse using porcine CD3e as the immunogen.Purity:Min. 95%Molecular weight:0 g/molCD11b antibody (PE)
CD11b antibody (PE) was raised in rat using peritoneal macrophages from C57 B1/6 x DBA/2 F1 hybrid mice as the immunogen.
Purity:Min. 95%Molecular weight:0 g/molCD45R antibody (Spectral Red)
CD45R antibody (Spectral Red) was raised in rat using abelson murine leukemia virus-induced pre-B tumor cells as the immunogen.
Purity:Min. 95%Molecular weight:0 g/molCD40 antibody (PE)
CD40 antibody (PE) was raised in rat using CD40 as the immunogen
Purity:Min. 95%Molecular weight:0 g/molCD107a antibody (FITC)
CD107a antibody (FITC) was raised in mouse using human CD107a/LAMP-1 as the immunogen.Purity:Min. 95%Molecular weight:0 g/molCytokeratin 18 Antibody
The Cytokeratin 18 Antibody is a diagnostic reagent used in Life Sciences for the detection of specific antibodies in human serum. It has high affinity and specificity for cytokeratin 18, a protein found in epithelial cells. This antibody can be used to study the expression and distribution of cytokeratin 18 in various tissues and cell types. Additionally, it can be used as a tool to investigate the role of cytokeratin 18 in cellular processes such as cell migration, adhesion, and proliferation. The Cytokeratin 18 Antibody is conjugated with sorafenib, which enhances its binding affinity and stability. This monoclonal antibody is immobilized on crystalline cellulose, allowing for easy handling and storage. With its high sensitivity and accuracy, the Cytokeratin 18 Antibody is an essential tool for researchers studying epithelial biology and related diseases.Purity:Min. 95%CD45 antibody (FITC)
CD45 antibody (FITC) was raised in mouse using chicken CD45 as the immunogen.
Purity:Min. 95%Molecular weight:0 g/molCD11a antibody (PE-CY7)
CD11a antibody (biotin) was raised in rat using murine CD11a (LFA-1a) as the immunogen.Purity:Min. 95%Molecular weight:0 g/molCD40 antibody (Allophycocyanin)
CD40 antibody (Allophycocyanin) was raised in rat using CD40 as the immunogenPurity:Min. 95%Molecular weight:0 g/molCD11a antibody (Azide Free)
CD11a antibody (Azide Free) was raised in rat using murine CD11a (LFA-1a) as the immunogen.
CD16 antibody (PE-CY7)
CD16 antibody (PE-CY5.5) was raised in rat using murine CD16/32 (CD16/Fc gamma II and CD32/Fc gamma III receptors)Purity:Min. 95%Molecular weight:0 g/molCD11a antibody (PE-CY7)
CD11a antibody (FITC) was raised in rat using murine CD11a (LFA-1a) as the immunogen.Purity:Min. 95%Molecular weight:0 g/molCD117 antibody (PE)
CD117 antibody (PE) was raised in mouse using human MO7e tumor cells as the immunogen.Purity:Min. 95%Molecular weight:0 g/molMirvetuximab
CAS:Mirvetuximab is an antibody-drug conjugate (ADC), which is a targeted cancer therapy designed to deliver cytotoxic agents specifically to cancer cells. This ADC is derived from a monoclonal antibody that specifically binds to the folate receptor alpha (FRα), a protein overexpressed in certain types of cancer cells, including ovarian cancer. The mode of action involves the binding of Mirvetuximab to FRα on the cancer cell surface, followed by internalization of the complex. Once inside the cell, the cytotoxic drug is released, leading to cell death.Mirvetuximab is primarily utilized in the treatment of FRα-positive ovarian cancer, particularly in patients with platinum-resistant disease. By exploiting the differential expression of FRα, Mirvetuximab can deliver lethal doses of chemotherapy directly to the cancer cells, thereby minimizing systemic toxicity. This targeted approach enhances the therapeutic index of the treatment, improving efficacy while reducing adverse effects typically associated with conventional chemotherapy. Ongoing clinical trials are exploring its potential in other FRα-expressing malignancies, making it a pivotal component in the advancement of personalized cancer therapy.
CD117 antibody (Spectral Red)
CD117 antibody (Allophycocyanin-CY7) was raised in rat using murine CD117/c-Kit as the immunogen.
Purity:Min. 95%Molecular weight:0 g/molCD30 antibody (biotin)
CD30 antibody (biotin) was raised in hamster using recombinant murine CD30 extracellular domain-mouse IgG1 fusion protein as the immunogen.
Purity:Min. 95%Molecular weight:0 g/molCD3 antibody (CY5)
CD3 antibody (CY5) was raised in mouse using the epsilon chain of CD3/T-cell antigen receptor complex as the immunogen.Purity:Min. 95%Molecular weight:0 g/molCD154 antibody (PE)
CD154 antibody (biotin) was raised in hamster using activated murine Th1 clone D1.6 as the immunogen.Purity:Min. 95%Molecular weight:0 g/molCD117 antibody (Spectral Red)
CD117 antibody (FITC) was raised in rat using murine CD117/c-Kit as the immunogen.Purity:Min. 95%Molecular weight:0 g/molCD38 antibody (biotin)
CD38 antibody (biotin) was raised in rat using CD38 as the immunogen.Purity:Min. 95%Molecular weight:0 g/molCD18 antibody (biotin)
CD18 antibody (biotin) was raised in rat using cell membrane lysates derived from murine T cell lymphoma BW5147 as the immunogen.Purity:Min. 95%Molecular weight:0 g/molCD16 antibody (Allophycocyanin)
CD16 antibody (Allophycocyanin) was raised in rat using murine CD16/32 (CD16/Fc gamma II and CD32/Fc gamma III receptors)Purity:Min. 95%Molecular weight:0 g/molPrim1 antibody
Prim1 antibody was raised in rabbit using the C terminal of Prim1 as the immunogenPurity:Min. 95%
